Patent directory · USPTO A61K / A61P
Patents matching “ras”
843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11033560
Triazole bisphosphonate geranylgeranyl diphosphate synthase inhibitors
granted -
US 11028083
Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
granted -
DE 102019218587
Kontrastmittelbasierte Gefäßdarstellung
granted -
US 11001592
DNA polymerase IIIC inhibitors and use thereof
granted -
US 10993948
RNA polymerase I inhibitors and uses thereof
granted -
US 10993936
Method of treating one or more symptoms of pulmonary fibrosis by administering inhibitors of nicotinamide phosphoribotransferase
granted -
US 10988472
Compounds and method for blocking transmission of malarial parasite
granted -
US 10980793
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 10974077
Low intensity focused ultrasound for treating cancer and metastasis
granted -
US 10975167
Method to reduce pulmonary arterial hypertension by administering inhibitors of nicotinamide phosphoribotransferase
granted -
US 10954287
Ras binding peptides and methods of use
granted -
US 10954192
Pyrrolomycins and methods of using the same
granted -
US 10945962
Controlled-release peptide compositions and uses thereof
granted -
US 10947509
Cell populations, methods of transdifferentiation and methods of use thereof
granted -
US 10940119
Nano-encapsulation using GRAS materials and applications thereof
granted -
US 10933071
Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
granted -
US 10927374
Compositions and methods for controlling arthropod parasite and pest infestations
granted -
US 10912779
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways
granted -
US 10894044
Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer
granted -
US 10889556
Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease
granted -
US 10883994
Identification of cancer stem cells markers and use of same for diagnosis and treatment
granted -
US 10881630
Creatine oral supplementation using creatine hydrochloride salt
granted -
US 10876134
Gene therapy for juvenile batten disease
granted -
US 10874752
MIBG analogs and uses thereof
granted